• Nie Znaleziono Wyników

Complete percutaneous repair after valvular surgery

N/A
N/A
Protected

Academic year: 2022

Share "Complete percutaneous repair after valvular surgery"

Copied!
2
0
0

Pełen tekst

(1)

Address for correspondence: Prof. Ignacio Cruz-Gonzalez, MD, PhD, University Hospital of Salamanca, Cardiology Department, Paseo San Vicente 58-182, Salamanca, 37007, Spain, tel: +34 923291100, ext. 55369, e-mail: cruzgonzalez.ignacio@gmail.com Received: 17.03.2018 Accepted: 26.05.2018

89 www.cardiologyjournal.org

INTERVENTIONAL CARDIOLOGY

Cardiology Journal 2019, Vol. 26, No. 1, 89–90 DOI: 10.5603/CJ.2019.0010 Copyright © 2019 Via Medica

ISSN 1897–5593

IMAGE IN CARDIOVASCULAR MEDICINE

Complete percutaneous repair after valvular surgery

Jose Carlos Moreno-Samos, Ignacio Cruz-Gonzalez, Manuel Barreiro-Perez, Rocio Gonzalez-Ferreiro, Monica Fuertes-Barahona, Pedro Luis Sanchez-Fernandez

University Hospital of Salamanca, Institute of Biomedical Research in Salamanca (IBSAL), Faculty of Medicine, University of Salamanca, CIBERCV, Salamanca, Spain

A 54-year-old woman with previous valvular surgery and permanent atrial fibrillation was admit- ted due to congestive heart failure.

In 2005, she underwent open-heart surgery when mitral valve was replaced (31-mm On-X mitral valve [CryoLife, Inc.]). Also a tricuspid annuloplasty (34-mm Edwards MC3 ring [Edwards Lifesciences]) and a left atrial appendage (LAA) ligation were completed.

A transesophageal echocardiography showed a lateral paravalvular leak (12 × 6 mm) in the pros- thetic mitral valve (Fig. 1A). Percutaneous closure of the paravalvular leak was performed (Fig. 1B, C) with an Amplatzer Vascular Plug III device (12 × 5 mm) (St. Jude Medical) with no residual regurgitation detected (Fig. 1D, E).

Subsequent to this, the patient was admitted because of recurrent cardioembolic strokes despite optimal treatment with warfarin.

Cardiac imaging evaluation detected a residual communication between the left atrium and previ- ously ligated LAA (Fig. 1F) and a percutaneous closure was decided upon.

After a LAA angiogram identified incomplete ligation (Fig. 1G), a 16 mm Amplatzer Vascular Plug II device (St. Jude Medical) was placed via 8 Fr Mullins sheath which sealed the orifice with no residual flow (Fig. 1H, I).

Incomplete LAA closure following surgical ligation occurs in 30–40% of cases and is as- sociated with a significantly increased risk of thrombus formation/thromboembolism. Although, percutaneous closure of incomplete ligation has been previously described, according to available research, this is the first reported case of a com- plete percutaneous repair of two complications after valvular surgery.

Conflict of interest: Dr. Ignacio Cruz-Gonzalez is proctor for St. Jude Medical. The other authors have no conflicts of interest to disclose.

(2)

A

G H

B

I F C

D E

90 www.cardiologyjournal.org

Cardiology Journal 2019, Vol. 26, No. 1

Figure 1. A. Two-dimensional transesophageal echocardiography (2D TEE) view of paravalvular regurgitation;

B. Fluoro image: the leak was crossed with a straight wire; C. Fluoro image: after venoarterial loop was created, an Amplatzer Vascular Plug III device (AVPIII) 12 × 5-mm device (yellow arrow) was deployed; D. 2D TEE image showing no paravalvular regurgitation; E. 3D TEE image showing AVPIII device; F. Computed tomography image showing incomplete left atrial appendage (LAA) ligation (blue arrow); G. Fluoro image: baseline left atrial appendage angiogram; H. Fluoro image: after deployment of an AVPII 16 mm device (white arrow); I. 3D TEE image showing the position of both devices.

Cytaty

Powiązane dokumenty

In addition, numerous real ‑life registries have reported favorable outcomes with Watchman, ACP, and Amulet devices in patients at higher bleeding risk and / or

‑enhanced chest computed tomography in the left anterior oblique view (D) and left lateral view (e) showing chicken ‑wing type left atrial appendage aneurysm (arrow); f

The secondary aims were to analyze causes of mortality and further hospitalization as well as adverse events, thromboembolism, and bleeding risk reduction during follow ‑up.. methods

PROTECT AF was the first randomised, clinical trial that demonstrated that left atrial appendage closure (LAAC) with Watchman device was non-inferior to warfarin in

An echogenic multilobulated mass (asterisk), in the fluid-filled left pulmonary artery recess of the pericardial transverse sinus mimics a thrombus in the left atrial appendage

Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients

Segmental atrial con- traction in patients restored to sinus rhythm after cardioversion for chronic atrial fibrillation: A colour Doppler tissue imaging study..

Modified apical four-chamber view of the left atrial appendage in a patient with moderate mitral ste- nosis.. Spontaneous echo-contrast and thrombus (arrow) in the hugely enlarged